Solventum Corporation (SOLV) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient n...
Solventum Corporation (SOLV) currently trades at a P/E ratio of 11.15 (historical range: 7.22–38.41, median: 25.98), placing it at the 45th percentile — near its historical average, P/S ratio of 1.93 (range: 1.31–3.06, 87th percentile — expensive relative to its history), EV/EBITDA of 252.95 (range: 6.95–254.04, 99th percentile).
Over the historical period (2024-08-30 to 2026-08-28), Solventum Corporation's P/E ratio has contracted by 64% over the observed period (from an average of 30.4 to 11.0).
Solventum Corporation appears overvalued relative to its own historical valuation range, trading at elevated multiples across most metrics.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 11.15 | 7.22 | 25.98 | 38.41 | 45th | near its historical average |
| P/S Ratio | 1.93 | 1.31 | 1.58 | 3.06 | 87th | expensive relative to its history |
| EV/EBITDA | 252.95 | 6.95 | 29.61 | 254.04 | 99th | expensive relative to its history |
| FCF Yield | 0.06 | 0.05 | 0.06 | 0.07 | 74th | below its historical average |